Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
BOI:EPA
Boiron SA
27,40 €
+4,58%
(+1,20) 1D
30-апр., 17:39:35 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BOI...
Open
26,60 €
High
27,40 €
Low
25,80 €
Mkt. cap
454,41 млн
Avg. vol.
3,45 миң
Volume
11,63 миң
P/E ratio
14,57
52-wk high
32,25 €
52-wk low
20,85 €
EPS
1,88 €
Shares outstanding
17,55 млн
No. of employees
3 миң
News stories
From sources across the web
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index. In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations. Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs". Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA
CEO-
Employees2,63 миң
Founded1932-ж., 7-июн.
Headquarters-
SectorPharmaceutical industry
Websiteboiron.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
122,82 млн
122,82 млн
127,73 млн
127,73 млн
Cost of goods sold
32,29 млн
32,29 млн
35,40 млн
35,40 млн
Cost of revenue
32,29 млн
32,29 млн
35,40 млн
35,40 млн
Research and development expenses
1,27 млн
1,27 млн
1,56 млн
1,56 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
79,15 млн
79,15 млн
78,49 млн
78,49 млн
Operating expense
79,55 млн
79,55 млн
76,77 млн
76,77 млн
Total operating expenses
111,85 млн
111,85 млн
112,17 млн
112,17 млн
Operating income
10,98 млн
10,98 млн
15,56 млн
15,56 млн
Other non operating income
-3,01 млн
-3,01 млн
-2,80 млн
-2,80 млн
EBT including unusual items
7,61 млн
7,61 млн
13,82 млн
13,82 млн
EBT excluding unusual items
7,60 млн
7,60 млн
13,83 млн
13,83 млн
Income tax expense
1,93 млн
1,93 млн
3,18 млн
3,18 млн
Effective tax rate
25,37%
25,37%
22,99%
22,99%
Other operating expenses
-864,50 миң
-864,50 миң
-3,28 млн
-3,28 млн
Net income
5,68 млн
5,68 млн
10,64 млн
10,64 млн
Net profit margin
4,63%
4,63%
8,33%
8,33%
Earnings per share
-
-
-
-
Interest and investment income
613,50 миң
613,50 миң
653,00 миң
653,00 миң
Interest expense
-220,50 миң
-220,50 миң
-335,00 миң
-335,00 миң
Net interest expenses
393,00 миң
393,00 миң
318,00 миң
318,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
16,52 млн
16,52 млн
16,84 млн
16,84 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer